Bevacizumab plus ipilimumab in patients with metastatic melanoma.

已完结 100 由医休发布于 2026/7/8 14:51:57

DOI:10.1158/2326-6066.CIR-14-0053
作者：F Stephen Hodi, Donald Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada, Wanyong Zeng, Anita Giobbie-Hurder, Michael B Atkins, Nageatte Ibrahi
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1158/2326-6066.CIR-14-0053

American Association for Cancer Research (AACR)

Abstract：Ipilimumab improves survival in advanced melanoma and can induce immune-mediated tumor vasculopathy. Besides promoting angiogenesis, vascular endothelial growth factor (VEGF) suppresses dend

应助信息

23小时前

Jone King

202607081532148521590.pdf 已采纳

1天前

Book学术机器人

2026/7/8 14:51:57 未找到该文献，机器人已退出，请等待人工下载

2026/7/8 14:51:57 Book学术AI机器人收到请求，开始寻找文献

2026/7/8 14:51:57 已向机器人发送请求

1天前

医休发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Surfactants Are Influencing the Photosensitized Multiphase Chemistry of SO2